Exploring how cannabinoid receptors affect the development of brain cells that produce myelin.
Investigating the role of cannabinoid receptors in oligodendrocyte development
This study is looking at how certain receptors in the brain might help the cells that make myelin, which is important for protecting nerves, and it hopes to find new ways to treat conditions like multiple sclerosis that affect myelin.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11006321 on NIH RePORTER |
What this research studies
This research investigates the role of cannabinoid receptors in the development of oligodendrocytes, the cells responsible for producing myelin in the central nervous system. By understanding the molecular mechanisms that drive oligodendrocyte development and myelination, the study aims to uncover potential therapeutic targets for neurological diseases like multiple sclerosis. The research utilizes proteomic analysis of cultured rat oligodendrocytes to identify key proteins involved in myelination, particularly focusing on the endocannabinoid system's influence during the differentiation of oligodendrocyte precursor cells. Patients may benefit from insights gained that could lead to new treatment options for myelin-related disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with neurological conditions that involve myelin disruption, particularly those with multiple sclerosis.
Not a fit: Patients with conditions unrelated to myelin production or neurological function may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurological diseases characterized by myelin damage, such as multiple sclerosis.
How similar studies have performed: Previous research has shown promise in targeting the endocannabinoid system for neurological conditions, suggesting potential for success in this area.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Miramontes, Tania G — Oregon Health & Science University
- Study coordinator: Miramontes, Tania G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.